GNI Group to acquire Ayumi Pharmaceutical for ¥44.8 billion

[
GNI Group to acquire Ayumi Pharmaceutical for ¥44.8 billion
[og_img]
https://www.investing.com/news/company-news/gni-group-to-acquire-ayumi-pharmaceutical-for-448-billion-93CH-4729715

Investing.com

I connected Claude to Gmail, and it got to know me scarily well — as well as saving me time

New SSD at COMPUTEX can remotely erase everything instantly, even from miles away, using a hidden cellular control system

Quordle hints and answers for Monday, June 8 (game #1596)

NYT Connections hints and answers for Monday, June 8 (game #1093)

Ex-Israeli Intelligence Official: Shockwaves of Trump’s “Take Over Gaza” Heard, Felt Across Region

What UK political parties are promising in the 2019 general election

Otto Warmbier’s parents want North Korea to suffer for their son’s death

Could a ‘youthquake’ cause Boris Johnson to lose the general election?

Pink 2026 Tony Awards: The Host’s Best Moments

Lawsuit Looks to Shut Down Donald Trump’s ‘UFC Freedom 250’ Fight

Tony Awards 2026 Winners: See the Complete List

Hulu’s Returning 16-Part ‘Breaking Bad Meets Weeds’ Series Still Has A Perfect Record

Japan’s economy cools on weak capex in Q1, revised data shows

Soccer-Perez wins Real Madrid vote to extend reign after rare election challenge

Asia markets tumble as tech rout deepens

Dollar climbs to two-month peak as Fed hike bets ramp up

The YouTuber who has become one of Gen Z’s most beloved celebrities

26 last-minute holiday gifts that are still thoughtful and unique

Practicing gratitude regularly can make you less stressed and sleep better

8 things millennials wish you would just stop getting them for the holidays

GNI Group to acquire Ayumi Pharmaceutical for ¥44.8 billion

Pink 2026 Tony Awards: The Host’s Best Moments

Japan’s economy cools on weak capex in Q1, revised data shows

Lawsuit Looks to Shut Down Donald Trump’s ‘UFC Freedom 250’ Fight

Soccer-Perez wins Real Madrid vote to extend reign after rare election challenge

Leave a reply Cancel reply